Bio-manufacturing instruments and techniques have become influential in everything from generating high yield pharmaceutical precursors, to biofuel conversion from biomass. Bioprocessing — the use of living organisms to create practical products and solutions — is currently being impacted by three ongoing trends in the industry: the emergence of continuous processing, the move towards single-use technologies and the focus on improved process productivity. This report specifically delves into different types of bioreactors, cell culture and media and supplements, filtration, and process chromatography, covering both upstream and downstream processes. Moving towards these goals has created many opportunities in a market that was over $8 billion in 2017.
Prices above are for universal license PDFs that can be shared with parent or subsidiary companies of the purchaser.
Objectives of a Market Analysis and Perspective Publication
- Provide subscribers with a detailed and concise global perspective of both upstream and downstream processes and what can aid continuous processing
- Provide the reader with valuable market figures and representations using secondary sources
- Reference for corporate planning, strategic marketing, business valuation, acquisition due diligence, and other business activities
SDi provides detailed information on both the upstream and downstream phases of bioprocessing, how demand is distributed across industries and regions, and how the market will change in the future. The results of a 38-question online survey of more than 200 bioprocess end-users from around the world is included, which provides substantive information on customer trends and opinions in the market. In addition, this report also includes an in-depth analysis of vendor shares in each area of the market. This report is the most accurate, detailed and concise market research document on the bioprocess market available anywhere.
This report is the most accurate, detailed and concise market research document on the bioprocessing market available anywhere.
If you have any question about the report and its contents, please contact us at email@example.com or call 703-778-3080 x19.
Major companies analyzed:
- Applikon Biotechnology
- Asahi Kasei
- BD Biosciences
- Cellgro (Corning)
- DHR (Pall, Danaher)
- Dow Chemical
- Finesse Solutions (Thermo Fisher)
- GE Healthcare
- Gibco (Thermo Fisher)
- HyClone (GE Healthcare)
- Infors HT
- Merck KGaA
- Pall (Danaher)
- Pall Biotech (Danaher)
- Pierre Guerin Technologies
- Zeta Holding